3M's Northridge, Calif. plant subject of Dec. 7 FDA warning letter on lab control practices.
Executive Summary
3M NORTHRIDGE, CALIF. PLANT FAILED "TO CONTROL LAB CONTROL MECHANISMS to assure that components, in-process materials and drug products conform to appropriate standards of identity, strength, quality and purity," FDA said in a Dec. 7 warning letter. Resulting from inspections of the manufacturing facility conducted Nov. 14-27, the letter notes several departures from current Good Manufacturing Practice regulations.